Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets
- 1 February 2008
- journal article
- Published by WHO Press in Bulletin of the World Health Organization
- Vol. 86 (2), 118-125
- https://doi.org/10.2471/blt.07.042010
Abstract
To standardize serological surveillance to compare rubella susceptibility in Australia and 16 European countries, and measure progress towards international disease-control targets. Between 1996 and 2004, representative serum banks were established in 17 countries by collecting residual sera or community sampling. Serum banks were tested in each country and assay results were standardized. With a questionnaire, we collected information on current and past rubella vaccination programmes in each country. The percentage of seronegative (< 4 IU/ml) children (2-14 years of age) was used to evaluate rubella susceptibility, and countries were classified by seronegativity as group I (< 5%), group II (5-10%) or group III (> 10%). The proportion of women of childbearing age without rubella protection (< or = 10 IU/ml) was calculated and compared with WHO targets of < 5%. Only Romania had no rubella immunization programme at the time of the survey; the remaining countries had a two-dose childhood schedule using the measles, mumps and rubella (MMR) vaccine. The percentage of susceptible children defined five countries as group I, seven as group II and four as group III. Women of childbearing age without rubella protection were < 5% in only five countries. Despite the low reported incidence in many countries, strengthening the coverage of the routine two-dose of MMR vaccine among children is needed, especially in group III countries. Catch-up campaigns in older age groups and selective targeting of older females are needed in many countries to ensure necessary levels of protective immunity among women of childbearing age.Keywords
This publication has 27 references indexed in Scilit:
- Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and AustraliaEpidemiology and Infection, 2007
- Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in IsraelVaccine, 2006
- Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st centuryEpidemiology and Infection, 2006
- Measles and Rubella in the World Health Organization European Region: Diversity Creates ChallengesThe Journal of Infectious Diseases, 2003
- New Horizons in the Control of Rubella and Prevention of Congenital Rubella Syndrome in the AmericasThe Journal of Infectious Diseases, 2003
- The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studiesEpidemiology and Infection, 2000
- Modelling rubella in EuropeEpidemiology and Infection, 2000
- Rubella in EuropeEpidemiology and Infection, 1991
- Selective Immunization: Protection of the IndividualClinical Infectious Diseases, 1985
- Vaccination against rubella and measles: quantitative investigations of different policiesEpidemiology and Infection, 1983